| | Per 2026 Note | | | Per 2030 Note | | | Per 2033 Note | | | Per 2043 Note | | | Total | |
Public offering prices | | | 100.000% | | | 100.000% | | | 100.000% | | | 100.000% | | | $2,950,000,000 |
Underwriting discounts | | | 0.400% | | | 0.625% | | | 0.650% | | | 0.875% | | | $18,837,500 |
Proceeds, before expenses, to Thermo Fisher | | | 99.600% | | | 99.375% | | | 99.350% | | | 99.125% | | | $2,931,162,500 |
BNP PARIBAS (All Notes) | | | Citigroup (All Notes) | | | Goldman Sachs & Co. LLC (All Notes) | | | Mizuho (All Notes) |
Barclays (2033 and 2043 Notes) | | | BofA Securities (2033 and 2043 Notes) | | | Credit Suisse (2026 Notes) | | | Deutsche Bank Securities (2026 Notes) |
HSBC (2026 Notes) | | | ING (2030 Notes) | | | J.P. Morgan (2026 and 2030 Notes) | | | Morgan Stanley (2030 Notes) |
MUFG (2030 Notes) | | | RBC Capital Markets (2033 Notes) | | | Scotiabank (2033 Notes) | | | SMBC Nikko (2033 Notes) |
US Bancorp (2043 Notes) | | | Wells Fargo Securities (2043 Notes) |
Academy Securities (All Notes) | | | AmeriVet Securities (All Notes) | | | Barclays (2026 and 2030 Notes) | | | Blaylock Van, LLC (All Notes) | | | BNY Mellon Capital Markets, LLC (All Notes) |
BofA Securities (2026 and 2030 Notes) | | | Credit Suisse (2030, 2033 and 2043 Notes) | | | Deutsche Bank Securities (2030, 2033 and 2043 Notes) | | | HSBC (2030, 2033 and 2043 Notes) | | | ING (2026, 2033 and 2043 Notes) |
J.P. Morgan (2033 and 2043 Notes) | | | KeyBanc Capital Markets (All Notes) | | | Loop Capital Markets (All Notes) | | | Morgan Stanley (2026, 2033 and 2043 Notes) | | | MUFG (2026, 2033 and 2043 Notes) |
NORDEA (All Notes) | | | RBC Capital Markets (2026, 2030 and 2043 Notes) | | | R. Seelaus & Co., LLC (All Notes) | | | SMBC Nikko (2026, 2030 and 2043 Notes) | | | Scotiabank (2026, 2030 and 2043 Notes) |
US Bancorp (2026, 2030 and 2033 Notes) | | | Wells Fargo Securities (2026, 2030 and 2033 Notes) |